文献速递甲状腺与浅表介入US

危险三角区T1N0M0甲状腺乳头状癌射频消融与微波消融的长期结局比较:双中心回顾性研究

Comparative Long-term Outcomes of RFA vs. MWA for T1N0M0 Papillary Thyroid Carcinoma in the Danger Triangle: A Dual-Center Retrospective Study.
PubMed 文献 · Acad Radiol · 2025-12-04

双中心回顾性研究纳入103例危险三角区单发T1N0M0甲状腺乳头状癌患者(62例射频消融、41例微波消融),随访71.97±9.72个月,两组肿瘤完全消融率均100%,疾病进展、无复发生存率无显著差异,但微波消融组轻微并发症及暂时性喉返神经损伤发生率更高。

要点

  • 危险三角区T1N0M0甲状腺乳头状癌射频与微波消融长期疾病控制相似。
  • 微波消融组轻微并发症及暂时性喉返神经损伤发生率高于射频消融组。
  • 术后前6个月微波消融组结节体积缩小率较低,6个月后两组无差异。

核心结论

  • 长期随访中,射频消融与微波消融对危险三角区甲状腺乳头状癌均提供高肿瘤消融率和相似的疾病控制,但微波消融并发症发生率更高。

研究设计与样本

  • 双中心回顾性研究,纳入2016年9月至2020年4月103例危险三角区单发T1N0M0甲状腺乳头状癌患者(年龄43.06±11.64岁,87例女性),其中62例行射频消融、41例行微波消融;结局包括疾病进展、无复发生存率、体积缩小率和并发症,并对T1a和T1b肿瘤进行亚组分析。

诊断标准与关键数值

  • 全部患者肿瘤消融率100%,93.2%完全消失;结节消失率射频消融组92.7% vs 微波消融组95.1%。
  • 随访71.97±9.72个月,疾病进展射频消融组9.75% vs 微波消融组4.84%(P=0.332),淋巴结转移0% vs 1.6%(P=0.414),复发肿瘤7.32% vs 3.23%(P=0.166),持续肿瘤2.44% vs 0%(P=0.314),无病生存率90.2% vs 95.1%(P=0.572)。
  • T1a和T1b肿瘤的疾病进展两组间亦无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare long-term efficacy and safety of ultrasound-guided radiofrequency ablation (RFA) and microwave ablation (MWA) in patients with papillary thyroid carcinoma (PTC) in the thyroid danger triangle.

METHODS: This dual-center retrospective study included 103 patients (age 43.06±11.64; 87 females) with solitary T1N0M0 PTC in the thyroid danger triangle from September 2016 to April 2020, of whom 62 underwent RFA and 41 underwent MWA. Outcomes included disease progression, recurrence-free survival (RFS), volume reduction rate (VRR), and complications, with subgroup analyses for T1a and T1b tumors.

RESULTS: All patients achieved 100% tumor ablation, with 93.2% complete disappearance. Nodule disappearance rates were similar between groups (92.7% vs 95.1%). In the first 6 months, the MWA group had larger nodule diameters and volumes, and a lower VRR (P<0.05), with no differences after 6 months. At follow-up of 71.97±9.72 months, there were no significant differences in disease progression (9.75% vs 4.84%, P=0.332), lymph node metastasis (0% vs 1.6%, P=0.414), Recurrent tumors (7.32% vs 3.23%, P=0.166), Persistent tumors (2.44% vs 0%, P=0.314) or Disease-free survival (90.2% vs 95.1%, P=0.572). There were also no significant differences in disease progression for T1a and T1b tumors. MWA had higher rates of minor complications and transient recurrent laryngeal nerve injury, but no significant difference in recovery time.

CONCLUSION: In long-term follow-up, both RFA and MWA provide high tumor ablation rates and similar disease control for PTC in the thyroid danger triangle, but MWA has a higher complication rate.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang DL, Yu MA, Chen S, et al. Comparative Long-term Outcomes of RFA vs. MWA for T1N0M0 Papillary Thyroid Carcinoma in the Danger Triangle: A Dual-Center Retrospective Study. Acad Radiol. 2025. PMID: 41350156. doi:10.1016/j.acra.2025.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。